Intensity Therapeutics’ Data on Lead Asset, INT230-6, Accepted for Three Presentations at Key Upcoming Clinical Oncology Conferences in November
- Tuesday, November 1, 2022, 7:03
- Finance
- Add a comment
Two Poster Presentations Will Be Made at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting Data on the Treatment of Metastatic Sarcomas Selected for Oral Podium Presentation at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting WESTPORT, Conn., Nov. 1,…
About the Author
adminasapcorp has written 41258 stories on this site.